CHRONIC SPONTANEOUS URTICARIA (CSU)
Clinical trials for CHRONIC SPONTANEOUS URTICARIA (CSU) explained in plain language.
Never miss a new study
Get alerted when new CHRONIC SPONTANEOUS URTICARIA (CSU) trials appear
Sign up with your email to follow new studies for CHRONIC SPONTANEOUS URTICARIA (CSU), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a new pill silence stubborn hives?
Disease control Not yet recruitingThis trial is testing an experimental oral medication called THB335 in adults with chronic spontaneous urticaria (CSU), a condition marked by persistent hives and itching that standard antihistamines don't fully control. Participants will take THB335 or a placebo alongside their …
Matched conditions: CHRONIC SPONTANEOUS URTICARIA (CSU)
Phase: PHASE2 • Sponsor: Calixis Inc. • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
Can a new pill quiet stubborn chronic hives?
Disease control Not yet recruitingThis phase II trial tests whether an experimental oral drug called TLL-018 can reduce itching and hives in adults with moderate-to-severe chronic spontaneous urticaria (CSU) that hasn't responded to standard antihistamines. Participants will take either a low or high dose of TLL-…
Matched conditions: CHRONIC SPONTANEOUS URTICARIA (CSU)
Phase: PHASE2 • Sponsor: Hangzhou Highlightll Pharmaceutical Co., Ltd • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
New pill aims to quiet chronic hives without the itch
Symptom relief Not yet recruitingThis early-stage trial tests an experimental tablet called Alpha-0261 in people with chronic spontaneous urticaria (long-lasting hives) and in healthy volunteers. The study checks the drug's safety, how the body processes it, and whether it reduces hive activity and itching. Part…
Matched conditions: CHRONIC SPONTANEOUS URTICARIA (CSU)
Phase: PHASE1 • Sponsor: AlphaMol Science Ltd. (Shanghai) • Aim: Symptom relief
Last updated Jul 08, 2026 00:00 UTC
-
New pill aims to stop chronic hives fast when antihistamines fail
Symptom relief Not yet recruitingThis early-phase trial tests a new drug called TLL-018 in 36 adults with moderate-to-severe chronic spontaneous urticaria (hives) that standard antihistamines can't control. The goal is to see how quickly TLL-018 reduces itching and hives after the first dose. Participants will r…
Matched conditions: CHRONIC SPONTANEOUS URTICARIA (CSU)
Phase: PHASE1, PHASE2 • Sponsor: Hangzhou Highlightll Pharmaceutical Co., Ltd • Aim: Symptom relief
Last updated Jul 03, 2026 00:00 UTC
-
Could a bacterial extract help tame stubborn hives?
Symptom relief Not yet recruitingThis study looks at whether adding a bacterial lysate (OM-85) to standard antihistamines can better control chronic spontaneous urticaria (CSU), also known as chronic hives. Researchers will observe 132 adults who have not responded well to antihistamines alone. The main goal is …
Matched conditions: CHRONIC SPONTANEOUS URTICARIA (CSU)
Sponsor: The Fourth Affiliated Hospital of Zhejiang University School of Medicine • Aim: Symptom relief
Last updated Jun 27, 2026 12:30 UTC
-
New shot could tame stubborn hives for good
Symptom relief Not yet recruitingThis study tests a new medicine called MG-K10 for people with chronic hives (itchy welts) that don't get better with standard allergy pills. About 226 teens and adults will receive either the drug or a placebo injection every few weeks. The goal is to see if MG-K10 reduces itchin…
Matched conditions: CHRONIC SPONTANEOUS URTICARIA (CSU)
Phase: PHASE3 • Sponsor: Shanghai Mabgeek Biotech.Co.Ltd • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC